160 related articles for article (PubMed ID: 33233853)
1. Optimized Encapsulation of the FLAP/PGES-1 Inhibitor BRP-187 in PVA-Stabilized PLGA Nanoparticles Using Microfluidics.
Behnke M; Vollrath A; Klepsch L; Beringer-Siemers B; Stumpf S; A Czaplewska J; Hoeppener S; Werz O; S Schubert U
Polymers (Basel); 2020 Nov; 12(11):. PubMed ID: 33233853
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity.
Shkodra-Pula B; Kretzer C; Jordan PM; Klemm P; Koeberle A; Pretzel D; Banoglu E; Lorkowski S; Wallert M; Höppener S; Stumpf S; Vollrath A; Schubert S; Werz O; Schubert US
J Nanobiotechnology; 2020 May; 18(1):73. PubMed ID: 32408877
[TBL] [Abstract][Full Text] [Related]
3. The roadmap to micro: Generation of micron-sized polymeric particles using a commercial microfluidic system.
Cruz-Acuña M; Kakwere H; Lewis JS
J Biomed Mater Res A; 2022 May; 110(5):1121-1133. PubMed ID: 35073454
[TBL] [Abstract][Full Text] [Related]
4. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release.
Morikawa Y; Tagami T; Hoshikawa A; Ozeki T
Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078
[TBL] [Abstract][Full Text] [Related]
5. Ethoxy acetalated dextran-based nanocarriers accomplish efficient inhibition of leukotriene formation by a novel FLAP antagonist in human leukocytes and blood.
Kretzer C; Shkodra B; Klemm P; Jordan PM; Schröder D; Cinar G; Vollrath A; Schubert S; Nischang I; Hoeppener S; Stumpf S; Banoglu E; Gladigau F; Bilancia R; Rossi A; Eggeling C; Neugebauer U; Schubert US; Werz O
Cell Mol Life Sci; 2021 Dec; 79(1):40. PubMed ID: 34971430
[TBL] [Abstract][Full Text] [Related]
6. Effect of Solvents, Stabilizers and the Concentration of Stabilizers on the Physical Properties of Poly(d,l-lactide-
Alkholief M; Kalam MA; Anwer MK; Alshamsan A
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456705
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis for the optimization of microfluidics-assisted nanoprecipitation method intended for the loading of small hydrophilic drugs into PLGA nanoparticles.
Chiesa E; Dorati R; Modena T; Conti B; Genta I
Int J Pharm; 2018 Jan; 536(1):165-177. PubMed ID: 29175645
[TBL] [Abstract][Full Text] [Related]
8. Microfluidic-assisted preparation of PLGA nanoparticles loaded with insulin: a comparison with double emulsion solvent evaporation method.
Kouhjani M; Jaafari MR; Kamali H; Abbasi A; Tafaghodi M; Mousavi Shaegh SA
J Biomater Sci Polym Ed; 2024 Feb; 35(3):306-329. PubMed ID: 38100556
[TBL] [Abstract][Full Text] [Related]
9. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
Bai X; Tang S; Butterworth S; Tirella A
Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
[TBL] [Abstract][Full Text] [Related]
10. Effect of Crystallinity on the Properties of Polycaprolactone Nanoparticles Containing the Dual FLAP/mPEGS-1 Inhibitor BRP-187.
Vollrath A; Kretzer C; Beringer-Siemers B; Shkodra B; Czaplewska JA; Bandelli D; Stumpf S; Hoeppener S; Weber C; Werz O; Schubert US
Polymers (Basel); 2021 Jul; 13(15):. PubMed ID: 34372160
[TBL] [Abstract][Full Text] [Related]
11. Ethoxy acetalated dextran nanoparticles for drug delivery: A comparative study of formulation methods.
Behnke M; Klemm P; Dahlke P; Shkodra B; Beringer-Siemers B; Czaplewska JA; Stumpf S; Jordan PM; Schubert S; Hoeppener S; Vollrath A; Werz O; Schubert US
Int J Pharm X; 2023 Dec; 5():100173. PubMed ID: 36908303
[TBL] [Abstract][Full Text] [Related]
12. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
Wang N; Wu XS; Li JK
Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of a highly hydrophilic drug in polymeric particles: A comparative study of batch and microfluidic processes.
Aboelela SS; Ibrahim M; Badruddoza AZM; Tran V; Ferri JK; Roper TD
Int J Pharm; 2021 Sep; 606():120906. PubMed ID: 34298100
[TBL] [Abstract][Full Text] [Related]
14. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics.
Roces CB; Christensen D; Perrie Y
Drug Deliv Transl Res; 2020 Jun; 10(3):582-593. PubMed ID: 31919746
[TBL] [Abstract][Full Text] [Related]
15. Microfluidic formulation of lipid/polymer hybrid nanoparticles for plasmid DNA (pDNA) delivery.
Santhanes D; Wilkins A; Zhang H; John Aitken R; Liang M
Int J Pharm; 2022 Nov; 627():122223. PubMed ID: 36155792
[TBL] [Abstract][Full Text] [Related]
16. Optimization of the Single Emulsion Method for Encapsulation of a Cancer Drug in Nanoparticles.
Holley CK; Sinquefield B; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1078-1081. PubMed ID: 31946081
[TBL] [Abstract][Full Text] [Related]
17. Fabrication and Optimization of Dp44mT-Loaded Nanoparticles.
Holley CK; Alkhalifah S; Majd S
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5733-5736. PubMed ID: 30441638
[TBL] [Abstract][Full Text] [Related]
18. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles.
Tao J; Chow SF; Zheng Y
Acta Pharm Sin B; 2019 Jan; 9(1):4-18. PubMed ID: 30766774
[TBL] [Abstract][Full Text] [Related]
19. The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Pergola C; Gerstmeier J; Mönch B; Çalışkan B; Luderer S; Weinigel C; Barz D; Maczewsky J; Pace S; Rossi A; Sautebin L; Banoglu E; Werz O
Br J Pharmacol; 2014 Jun; 171(12):3051-64. PubMed ID: 24641614
[TBL] [Abstract][Full Text] [Related]
20. A robust systematic design: Optimization and preparation of polymeric nanoparticles of PLGA for docetaxel intravenous delivery.
Rafiei P; Haddadi A
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109950. PubMed ID: 31499976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
